Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Menon, Y.
Right arrow Articles by Espinoza, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menon, Y.
Right arrow Articles by Espinoza, L. R.
Related Collections
Right arrow Systemic Sclerosis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 1273-1274
© 2003 British Society for Rheumatology

Letter to the Editor

Pancytopenia in a patient with scleroderma treated with infliximab

Y. Menon, E. Cucurull and L. R. Espinoza

Rheumatology, LSUHSC, New Orleans, LA, USA

Correspondence to: L. R. Espinoza. E-mail: yaminimenon@msn.com

The first 10% of the full text of this article appears below.

SIR, We read with interest the report by Marchesoni et al. [1] of life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient treated initially with methotrexate and later switched to leflunomide plus infliximab. The authors suggest that leflunomide may have been responsible for the pancytopenia . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. K. Pathare, C. Heycock, and J. Hamilton
TNF{alpha} blocker-induced thrombocytopenia
Rheumatology, October 1, 2006; 45(10): 1313 - 1314.
[Full Text] [PDF]

Home page
 CMAJHome page
C. Phelan and E. Wooltorton
Infliximab and serious hematologic events
Can. Med. Assoc. J., October 26, 2004; 171(9): 1045 - 1045.
[Full Text] [PDF]